Raymond James stock holds firm near recent highs after steady session
Published on 09/18/2026 at 19:34 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Raymond James Financial stock (ISIN US7547301090) closed at USD 163.77 on the New York Stock Exchange on September 17, 2026, marking a mild decline of about 0.5% from the prior session but leaving the shares near recent highs around USD 164.10 as cited in current market overviews.
Stock trades close to analyst target range
Recent data from equity portals show Raymond James Financial stock quoted at USD 163.77 with an indicative intraday level around USD 164.10 as of September 18, 2026, keeping the stock in a tight range after its latest advance. One market overview lists the previous close at USD 163.77 USD on the NYSE on September 17, 2026, with a daily move of minus 0.49% for that session, suggesting a brief pause after earlier gains.
In the same data snapshot, analysts’ average target price for Raymond James Financial stands at USD 186.00, implying upside of more than 10% compared with the current share price around the mid-USD 160s. This gap between the market price and the average target underlines that, despite the recent consolidation near a 52-week high region, the sell-side still sees scope for further appreciation. For investors, the combination of a relatively high current valuation level and a double-digit percentage gap to consensus targets frames the near-term risk-reward profile.
Fundamentals and earnings backdrop remain the anchor
The current trading stance of Raymond James stock is increasingly shaped by its most recent quarterly and fiscal-year figures, even though these results were reported before September 2026. Historical: in a recent fiscal year within the last two years, the company reported multi-billion-dollar revenue and solid net income, underpinned by strong performance in its private client group and capital markets segments. Those figures, while no longer current for September 2026, still serve as a reference point when investors assess whether the present valuation around USD 163.77 per share adequately reflects the firm’s earnings power.
On the interim-report side, the company’s latest available quarterly or half-year numbers, reported within the last nine months, showed continued growth in fee-based assets and resilient net interest income compared with the prior-year period. Historical comparison figures from that report indicated that revenue and earnings were higher than in the same quarter a year earlier, documenting that Raymond James had managed to expand its top line and profit base despite a mixed market backdrop. Although these historical fundamentals no longer qualify as fresh same-day key figures, they provide context for why analysts remain constructive on the stock.
Analyst sentiment and sector signals provide context
While the latest week’s headlines have focused more on Raymond James as an analyst firm for other companies rather than on Raymond James Financial’s own shares, these calls still help illuminate how the firm views risk and opportunity in the broader market. For example, an Investing.com note on September 18, 2026 reports that Raymond James raised its price target for Targa Resources to USD 335 while maintaining a Strong Buy rating, signaling confidence in select energy infrastructure names as part of its wider coverage universe.Investing.com In another example, a Dow Jones Newswires item relayed via TradingView on September 18, 2026 highlights that Raymond James raised the price target for Oscar Health to USD 42.00 per share from USD 34.00, again reflecting an active stance on growth-oriented names in its coverage.TradingView
These external calls do not directly change Raymond James Financial’s own earnings, but they show that the firm continues to take differentiated views in key sectors. For shareholders of Raymond James Financial, such activity can be a qualitative signal that the company’s research and advisory platform remains engaged across energy, healthcare and other cyclical industries, supporting potential fee income and trading revenues. At the same time, the breadth of these calls underscores one of the structural risks for Raymond James: the company operates in markets where sentiment and valuations can shift quickly, and misjudged sector bets or a downturn in deal activity could weigh on its future quarterly results.
Price level and investor perspective
As of September 18, 2026, Raymond James Financial stock is quoted around USD 163.77 on the NYSE, close to levels such as USD 164.10 mentioned in real-time overviews and below an average analyst target of USD 186.00. With the shares trading near the upper end of their recent range and the consensus still pointing to double-digit percentage upside, investors will be watching the next earnings release and any changes in the rate environment or capital markets activity to judge whether the current price adequately reflects the company’s earnings trajectory.
Raymond James stock facts
- Company: Raymond James Financial Inc.
- ISIN: US7547301090
- Ticker: RJF
- Trading venue: NYSE
- Price (as of September 18, 2026): 163.77 USD
- Market capitalization: [value] USD (as of September 18, 2026)
- Sector / Industry: Financial services / Wealth management
- Index membership: S&P 500
